An observational study in Covid19, sponsored by Jaseng Hospital of Korean Medicine. Completed at 1 site in Korea, Republic of. Per ClinicalTrials.gov, last updated 2022-07-22.
Sponsored by Jaseng Hospital of Korean Medicine · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 90 studies in COVID-19 with a site in Korea, Republic of — 11 open to participants now, 19 under way, 6 of them phase 3. COVID-19 · Korea, Republic of.
Among the 90 studies in COVID-19 with a site in Korea, Republic of, this one is the 11th largest by enrollment of the 18 observational ones that give a count, is one of 29 that started in 2020, is one of 18 observational ones, and was the 17th registered.
7,996 studies on the registry are indexed under COVID-19; 469 are open to participants now.
Browse COVID-19 studies →11 of the 90 studies in COVID-19 with a site in Korea, Republic of are open now. Recruiting first, the newest first:
Pfizer · Sites in Korea, Republic of, United States, Argentina and 15 more countries
Ages 18+
Pfizer · Sites in Korea, Republic of, United States, Argentina and 16 more countries
Ages 12+
Merck Sharp & Dohme LLC · Sites in Korea, Republic of, United States, Argentina and 21 more countries
Ages 18+
Jaehoon Ko · Sites in Korea, Republic of
Ages 19+
Pfizer · Sites in Korea, Republic of
Ages 19+
A study can be open while its sites in Korea, Republic of have not opened yet or have stopped. Only those recruiting at a site in Korea, Republic of →
Of the 356 COVID-19 studies recruiting now, 205 (58%) set no upper age limit and 84 (24%) stop at 75 or younger; 90 take children under 18; 135 take healthy volunteers.
This study: all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
90 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 20 · Phase 2 31 · Phase 3 30 · Phase 4 2
First in 2018; this study’s year is marked. 29 started in 2020.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 485 is above the median of 268 across 3,209 observational studies indexed under COVID-19.
Median enrollment 253 across the 72 interventional studies, 730 across the 18 observational. Of the 58 that completed or were terminated, 21 (36%) have results posted.
This tab as a report to print or save as PDF → With an account.
64 of 90 have an industry lead sponsor. The 10 most frequent:
Jaseng Hospital of Korean Medicine is the lead sponsor of 14 studies on the registry; 1 is open to participants now.
Jaseng Hospital of Korean Medicine has 1 study filed under COVID-19 — fewer than ten, so there is no comparison to draw.
7 of the studies in COVID-19 with a site in Korea, Republic of that are under way reach primary completion within a year, 3 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07013474Phase 3PfizerA Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised | 2027-09-28 |
| NCT06679140Phase 3PfizerA Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease | 2027-10-01 |
| NCT05624450Phase 3AstraZenecaEfficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen | 2027-11-04 |
| NCT06613984PfizerKorean Post Marketing Surveillance for Comirnaty Injection (Bretovameran) | 2026-12-30 |
| NCT05032976PfizerKorea Comirnaty Post-marketing Surveillance | 2027-01-24 |
Add all 7 to your calendar (.ics) → With an account.
Among the 90 studies in COVID-19 with a site in Korea, Republic of, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The objectives of this study are to report the response strategy to prevent COVID-19 spread implemented at a Korean medicine hospital, and the satisfaction survey results regarding its preventive measures.
The objectives of this study are (1) to report the response strategy to prevent COVID-19 spread implemented at a Korean medicine hospital situated in Seoul, Korea, (2) to describe patient visit trends compared to the number of confirmed COVID-19 cases during the COVID-19 peak in February - April 2020, and (3) to provide results of a satisfaction survey regarding its preventive measures.
Inpatients hospitalized and outpatients visiting Jaseng Hospital of Korean medicine during March 23-25, 2020
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Jaseng Hospital of Korean medicine conducted a pen and paper survey on patient satisfaction with regard to its COVID-19 response in inpatients hospitalized and outpatients visiting during March 23-25, 2020.
Other: Survey
The patient satisfaction survey consisted of 8 items, including 7 Likert scale questions and 1 multiple choice question.
Satisfactory service regarding hospital response to COVID-19
Multiple choice question on satisfactory service regarding hospital response to COVID-19, if any
Time frame: Baseline (time of current visit)
Feelings of apprehension regarding hospital visits
Likert scale question on level of feelings of apprehension before hospital visits due to COVID-19
Time frame: Baseline (time of current visit)
Medical staff wearing of facial masks and hand hygiene
Likert scale question on level of maintenance of wearing of facial masks and hand hygiene in medical staff
Time frame: Baseline (time of current visit)
Cleanliness and sterilization of hospital facilities
Likert scale question on level of cleanliness and sterilization of hospital facilities with regard to COVID-19 spread prevention
Time frame: Baseline (time of current visit)
Convenience and accessibility of hand sanitizers
Likert scale question on level of convenience and accessibility of hand sanitizers
Time frame: Baseline (time of current visit)
Helpfulness and readability of posters and stand-up banners
Likert scale question on level of helpfulness and readability of posters and stand-up banners with COVID-19 information in the hospital
Time frame: Baseline (time of current visit)
Satisfaction with hospital safety measures for COVID-19
Likert scale question on level of satisfaction with hospital safety measures for COVID-19
Time frame: Baseline (time of current visit)
Recommendation of hospital to friends and family
Likert scale question on level of recommendation of this hospital to friends and family concerned with visiting hospitals due to COVID-19
Time frame: Baseline (time of current visit)
Plan to share: No
No publications or documents are linked to this record.
Ran from Jun 2020 to primary completion in Aug 2020, 2 months.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Jul 2022. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Jaseng Hospital of Korean Medicine